• Home
  • Recurrent BRAF kinase fusions in melanocytic tumors offer an opportunity for targeted therapy.

Recurrent BRAF kinase fusions in melanocytic tumors offer an opportunity for targeted therapy.

Author List
Botton T, Yeh I, Nelson T, Vemula SS, Sparatta A, Garrido MC, Allegra M, Rocchi S, Bahadoran P, McCalmont TH, LeBoit PE, Burton EA, Bollag G, Ballotti R, Bastian BC
Publication
Pigment cell & melanoma research
Publication ID (Profile URL)
https://researcherprofiles.org/profile/1173039
Publication Year
2013
PubMed ID
23890088
Publication Title
Botton T, Yeh I, Nelson T, Vemula SS, Sparatta A, Garrido MC, Allegra M, Rocchi S, Bahadoran P, McCalmont TH, LeBoit PE, Burton EA, Bollag G, Ballotti R, Bastian BC. Recurrent BRAF kinase fusions in melanocytic tumors offer an opportunity for targeted therapy. Pigment Cell Melanoma Res. 2013 Nov; 26(6):845-51.